| Literature DB >> 34216426 |
Shayna Sharma1, Mostafa Kamal Masud2,3,4, Yusuf Valentino Kaneti2, Prarthana Rewatkar5, Aayushi Koradia5, Md Shahriar A Hossain2,6, Yusuke Yamauchi2,3, Amirali Popat5,7, Carlos Salomon1,8.
Abstract
Extracellular vesicles (EVs) can transfer intercellular messages in various (patho)physiological processes and transport biomolecules to recipient cells. EVs possess the capacity to evade the immune system and remain stable over long periods, identifying them as natural carriers for drugs and biologics. However, the challenges associated with EVs isolation, heterogeneity, coexistence with homologous biomolecules, and lack of site-specific delivery, have impeded their potential. In recent years, the amalgamation of EVs with rationally engineered nanostructures has been proposed for achieving effective drug loading and site-specific delivery. With the advancement of nanotechnology and nanoarchitectonics, different nanostructures with tunable size, shapes, and surface properties can be integrated with EVs for drug loading, target binding, efficient delivery, and therapeutics. Such integration may enable improved cellular targeting and the protection of encapsulated drugs for enhanced and specific delivery to target cells. This review summarizes the recent development of nanostructure amalgamated EVs for drug delivery, therapeutics, and real-time monitoring of disease progression. With a specific focus on the exosomal cargo, diverse drug delivery system, and biomimetic nanostructures based on EVs for selective drug delivery, this review also chronicles the needs and challenges of EV-based biomimetic nanostructures and provides a future outlook on the strategies posed.Keywords: biomimetic nanostructures; drug delivery system; exosomes; extracellular vesicles (EVs); nanoarchitectonics; nanomedicine
Year: 2021 PMID: 34216426 DOI: 10.1002/smll.202102220
Source DB: PubMed Journal: Small ISSN: 1613-6810 Impact factor: 13.281